Targeting bacterial virulence: Inhibitors of type III secretion in Yersinia

Chemistry and Biology

Volumn 10, Issue 3, 2003, Pages 241-249

  Kauppi, Anna M ^a   Nordfelth, Roland ^a   Uvell, Hanna ^a   Wolf Watz, Hans ^a   Elofsson, Mikael ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); NEGIBACTERIA; YERSINIA; YERSINIA PSEUDOTUBERCULOSIS;

EID: 0037350267     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(03)00046-2     Document Type: Article

References (41)

1. Cornelis G.R. Molecular and cell biology aspects of plague. Proc. Natl. Acad. Sci. USA. 97:2000;8778-8783.
2. Cornelis G.R., Wolf-Watz H. The Yersinia Yop virulon. A bacterial system for subverting eukaryotic cells Mol. Microbiol. 23:1997;861-867.
3. Perry R.D., Fetherston J.D. Yersinia pestis - etiologic agent of plague. Clin. Microbiol. Rev. 10:1997;35-66.
4. Gauthier A., Finlay B.B. Type III secretion system inhibitors are potential antimicrobials. ASM News. 68:2002;383-387.
5. Goldschmidt R.M., Macielag M.J., Hlasta D.J., Barrett J.F. Inhibition of virulence factors in bacteria. Curr. Pharm. Des. 3:1997;125-142.
6. Alksne L.E., Projan S.J. Bacterial virulence as target for antimicrobial chemotherapy. Curr. Opin. Biotechnol. 11:2000;625-636.
7. Stockwell B.R. Frontiers in chemical genetics. Trends Biotechnol. 18:2000;449-455.
8. Shogren-Knaak M.A., Alaimo P.J., Shokat K.M. Recent advances in chemical approaches to the study of biological systems. Annu. Rev. Cell Dev. Biol. 17:2001;405-433.
9. Ward G.E., Carey K.L., Westwood N.J. Using small molecules to study big questions in cellular microbiology. Cell. Microbiol. 4:2002;471-482.
10. Hueck C.J. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 62:1998;379-433.
11. Cornelis G.R., Van Gijsegem F. Assembly and function of type III secretory systems. Annu. Rev. Microbiol. 54:2000;735-774.
12. Young G.M., Schmiel D.H., Miller V.L. A new pathway for the secretion of virulence factors by bacteria. The flagellar export apparatus funtions as a protein-secretion system Proc. Natl. Acad. Sci. USA. 96:1999;6456-6461.
13. Young B.M., Young G.M. YplA is exported by the Ysc, Ysa, and flagellar type III secretion systems of Yersinia enterecolityica. J. Bacteriol. 184:2002;1324-1334.
14. Rosqvist R., Håkansson S., Forsberg Å., Wolf-Watz H. Functional conservation of the secretion and translocation machinery for virulence proteins of yersiniae, salmonellae, and shigellae. EMBO J. 14:1995;4187-4195.
15. Galimand M., Guiyoule A., Gerbaud G., Rasoamanana B., Chanteau S., Carniel E., Courvalin P. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N. Engl. J. Med. 337:1997;677-680.
16. Guiyoule A., Gerbaud G., Buchrieser C., Galimand M., Rahalison L., Chanteau S., Courvalin P., Carniel E. Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis. Emerg. Infect. Dis. 7:2001;43-48.
17. Hawley R.J., Eitzen E.M. Jr. Biological weapons - a primer for microbiologists. Annu. Rev. Microbiol. 55:2001;235-253.
18. Inglesby T.V., Dennis D.T., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., Fine A.D., Friedlander A.M., Hauer J., Koerner J.F.et al. Plague as a biological weapon. JAMA. 283:2000;2281-2290.
19. Cornelis G.R., Boland A., Boyd A.P., Geujien C., Iriarte M., Neyt C., Sory M.-P., Stainier I. The virulence plasmid of Yersinia, an antihost genome. Microbiol. Mol. Biol. Rev. 62:1998;1315-1352.
20. de Rouvroit C.L., Sluiters C., Cornelis G.R. Role of the transcriptional activator, VirF, and temperature in the expression of the pYV plasmid genes of Yersinia entereocolitica. Mol. Microbiol. 6:1992;395-409.
21. Petterson J., Nordfelth R., Dubinina E., Bergman T., Gustafsson M., Magnusson K.E., Wolf-Watz H. Modulation of virulence factor expression by pathogen target cell contact. Science. 273:1996;1231-1233.
22. 2+ deficiency on macromolecular synthesis and adenylate energy charge in Yersinia pestis. J. Baceriol. 139:1979;792-799.
23. Rimpiläinen M., Forsberg Å., Wolf-Watz H. A novel protein, LcrQ, involved in the low-calcium response of Yersinia pseudotuberculosis shows extensive homology to YopH. J. Bacteriol. 174:1992;3355-3363.
24. Olsson O., Koncz C., Szalay A.A. The use of the luxA gene of the bacterial luciferase operon as a reporter gene. Mol. Gen. Genet. 215:1988;1-9.
25. Forsberg Å., Rosqvist R. In vivo expression of virulence genes of Yersinia pseudotuberculosis. Infect. Agents Dis. 2:1994;275-278.
26. Bölin I., Wolf-Watz H. Molecular cloning of the temperature-inducible outer membrane protein 1 of Y. pseudotuberculosis. Infect. Immun. 43:1984;72-78.
27. Bölin I., Wolf-Watz H. The plasmid-encoded Yop2b protein of Yersinia pseudotuberculosis is a virulence determinant regulated by calcium and temperature at the level of transcription. Mol. Microbiol. 2:1988;237-245.
28. Forsberg, Å. (1989). The low calcium stimulon of Yersinia pseudotuberculosis: Regulation and function of the yopE gene. PhD thesis, Umeå University, Umeå, Sweden.
29. Young G.M., Badger J.L., Miller V.L. Motility is required to initiate host cell invasion by Yersinia enterocolitica. Infect. Immun. 68:2000;4323-4326.
30. Foultier B., Troisfontaines P., Vertommen D., Marenne M.N., Rider M., Parsot C., Cornelis G.R. Identification of substrates and chaperones from the Yersinia enterocolitica 1B Ysa type III secretion system. Infect. Immun. 71:2003;242-253.
31. Dobrova B.N., Dimoglo S., Chumakov Y.M. Study of the relationship between chemical structure and antimicrobial activity in a series of hydrazine-based coordination compounds. Arzneimittelforschung. 50:2000;747-751.
32. Haksar C.N., Malhotra R.C., Pandya G., Sethi R.K. Antibacterial activity of hydrazones of some substituted benzohydrazides. Life Sci. 12B:1974;13-16.
33. Offe H.A., Siefken W., Domagk G. Hydrazinderivate und ihre Wirksamkeit gegenüber Mycobacterium tuberculosis. Naturforsch. Teil B. 7:1952;446-462.
34. Ainscough E.W., Brodie A.M., Denny W.A., Finlay G.J., Gothe S.A., Ranford J.D. Cytotoxicity of salicylaldehyde benzoylhydrazone analogs and their transition metal complexes. quantitative structure-activity relationships J. Inorg. Biochem. 77:1999;125-133.
35. Merck & Co. Inc. (2001). Clioxanide. In Merck Index, 13th Edition. Merck & Co. Inc., Whitehouse Station, NJ, pp. 411-412.
36. Ozawa I., Takeuchi I., Yamamoto K., Hamada Y., Tomiyoshi I., Kuwahara M., Tagaki T. Synthesis and antimicrobial activity of salicylanilide derivatives II. Chem. Pharm. Bull. (Tokyo). 32:1984;305-312.
37. Terada H., Goto S., Yamamoto K., Takeuchi I., Hamada Y., Keishiro M. Structural requirements of salicylanilides for uncoupling activity in mitochondria. quantitative analysis of structure-uncoupling relationships Biochim. Biophys. Acta. 936:1988;504-512.
38. Stephenson K., Yamaguchi Y., Hoch J.A. The mechanism of action of inhibitors of bacterial two-component signal transduction systems. J. Biol. Chem. 275:2000;38900-38904.
39. Macielag M.J., Demers J.P., Fraga-Spano S.A., Hlasta D.J., Johnson S.G., Kanojia R.M., Russell R.K., Sui Z., Weidner-Wells M.A., Werblood H.et al. Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria. J. Med. Chem. 41:1998;2939-2945.
40. Mikhailitsyn F.S., Lebedeva M.N., Bayandina D.G., Kozyreva N.P., Lychko N.D., Bolotina L.A., Drusvyatskaya S.K., Naidenova A.S. Search for new antiparasitic agents 9. Antihelmintic action of haloid-containing sulfonamidobenzamides. Med. Parazitol. (Mosk). 6:1991;52-53.
41. Mikhailitsyn F.S., Lebedeva M.N., Kozyreva N.P., Lychko N.D., Drusvyatskaya S.K., Uvarova N.A. Search for new antiparasitic agents 3. Synthesis of haloid-containing sulfamidobenzamides with benzo-2,1,3-thiazole residue in sulfamide group and the study of their acute toxicity. Med. Parazitol. (Mosk). 2:1991;36-38.